Simplex Trading
UTHR icon

Simplex Trading’s United Therapeutics UTHR Stock Holding History

Simplex Trading’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.4M Buy
+10,800
New +$5.38M ﹤0.01% 950
2025
Q4 		– Sell
-18,400
Closed -$7.71M – 10161
2025
Q3 		$7.71M Buy
18,400
+4,200
+30% +$1.41M ﹤0.01% 1141
2025
Q2 		$4.08M Buy
14,200
+10,100
+246% +$3.02M ﹤0.01% 1518
2025
Q1 		$1.26M Sell
4,100
-2,400
-37% -$822K ﹤0.01% 2472
2024
Q4 		$2.29M Sell
6,500
-3,800
-37% -$1.4M ﹤0.01% 2074
2024
Q3 		$3.69M Sell
10,300
-4,300
-29% -$1.45M ﹤0.01% 1733
2024
Q2 		$4.65M Sell
14,600
-14,500
-50% -$3.84M ﹤0.01% 1486
2024
Q1 		$6.68M Buy
29,100
+18,600
+177% +$4.2M ﹤0.01% 1381
2023
Q4 		$2.31M Buy
10,500
+7,700
+275% +$1.77M ﹤0.01% 2243
2023
Q3 		$632K Sell
2,800
-800
-22% -$184K ﹤0.01% 3157
2023
Q2 		$794K Buy
3,600
+400
+13% +$88.6K ﹤0.01% 2821
2023
Q1 		$716K Sell
3,200
-7,100
-69% -$1.75M ﹤0.01% 2910
2022
Q4 		$2.86M Sell
10,300
-5,300
-34% -$1.34M ﹤0.01% 1592
2022
Q3 		$3.27M Buy
15,600
+12,100
+346% +$2.71M ﹤0.01% 1529
2022
Q2 		$824K Sell
3,500
-11,000
-76% -$2.24M ﹤0.01% 2840
2022
Q1 		$2.6M Sell
14,500
-200
-1% -$38.1K ﹤0.01% 1834
2021
Q4 		$3.18M Sell
14,700
-10,300
-41% -$2.02M ﹤0.01% 1584
2021
Q3 		$4.62M Buy
25,000
+100
+0.4% +$19.7K ﹤0.01% 1275
2021
Q2 		$4.47M Buy
+24,900
New +$4.74M ﹤0.01% 1280
2021
Q1 		– Sell
-150
Closed -$2.28M – 10118
2020
Q4 		$2.28M Buy
150
+47
+46% +$6.17K ﹤0.01% 1649
2020
Q3 		$1.04M Buy
103
+48
+87% +$5.27K ﹤0.01% 2194
2020
Q2 		$665K Buy
55
+5
+10% +$563 ﹤0.01% 2568
2020
Q1 		$474K Sell
50
-52
-51% -$4.94K ﹤0.01% 2647
2019
Q4 		$898K Buy
102
+39
+62% +$3.43K ﹤0.01% 2191
2019
Q3 		$502K Buy
63
+47
+294% +$3.79K ﹤0.01% 2621
2019
Q2 		$124K Sell
16
-126
-89% -$11.8K ﹤0.01% 3969
2019
Q1 		$1.67M Buy
142
+140
+7,000% +$16.3K ﹤0.01% 1539
2018
Q4 		$21K Sell
2
-168
-99% -$19.5K ﹤0.01% 5293
2018
Q3 		$2.17M Sell
170
-94
-36% -$11.6K 0.01% 1183
2018
Q2 		$2.99M Buy
264
+134
+103% +$14.7K 0.01% 862
2018
Q1 		$23K Buy
130
+88
+210% +$11.2K ﹤0.01% 3233
2017
Q4 		$48K Buy
42
+30
+250% +$3.81K ﹤0.01% 2492
2017
Q3 		$2K Hold
12
– – ﹤0.01% 5175
2017
Q2 		$61K Sell
12
-60
-83% -$7.49K ﹤0.01% 2211
2017
Q1 		$110K Sell
72
-32
-31% -$4.85K ﹤0.01% 1659
2016
Q4 		$115K Sell
104
-57
-35% -$7.28K 0.01% 1422
2016
Q3 		$37K Sell
161
-28
-15% -$3.36K ﹤0.01% 2375
2016
Q2 		$23K Buy
189
+69
+58% +$7.7K ﹤0.01% 2786
2016
Q1 		$14K Buy
120
+93
+344% +$11.8K ﹤0.01% 3168
2015
Q4 		$26K Sell
27
-16
-37% -$2.33K ﹤0.01% 2484
2015
Q3 		$4K Sell
43
-40
-48% -$6.42K ﹤0.01% 4215
2015
Q2 		$41K Buy
83
+36
+77% +$6.48K ﹤0.01% 1851
2015
Q1 		$36K Sell
47
-62
-57% -$9.45K ﹤0.01% 1815
2014
Q4 		$41K Buy
+109
New +$14K 0.01% 1509

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Simplex Trading's UTHR Position: Q4 2025 in Review

Simplex Trading sold out of United Therapeutics (UTHR) in Q4 2025, closing a stake of 171 shares — an estimated $71K sold.

Simplex Trading first reported a position in UTHR in Q1 2015 and held it in 19 quarters. The position peaked at $1.83M in Q4 2017. 837 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

  • Simplex Trading reported no remaining United Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 171 United Therapeutics shares in Q4 2025, an estimated $71K.
  • Simplex Trading first reported a position in United Therapeutics in Q1 2015 and held it in 19 quarters.
  • Simplex Trading's United Therapeutics position peaked at $1.83M in Q4 2017.
  • 837 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.